Samsrita Labs Limited (BOM:539267)

India flag India · Delayed Price · Currency is INR
18.89
+1.55 (8.94%)
At close: Mar 12, 2026
Market Cap429.74M +39.1%
Revenue (ttm)n/a
Net Income-78.25M
EPS-4.17
Shares Out22.75M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,001
Average Volume373
Open18.00
Previous Close17.34
Day's Range16.60 - 18.90
52-Week Range12.19 - 26.04
Beta0.05
RSI46.13
Earnings DateApr 24, 2026

About Samsrita Labs

Samsrita Labs Limited operates as a biopharmaceutical company in India. The company offers DNA, RNA, and chromosomal-based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and prenatal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype, and fluorescence in-situ hybridization analysis. It is also involved in the stem cell research a... [Read more]

Industry Commercial Physical and Biological Research
Founded 1996
Employees 4
Stock Exchange Bombay Stock Exchange
Ticker Symbol 539267
Full Company Profile

Financial Performance

Financial Statements